History of Attorney General Recusal, and More from CRS
“The recent announcement by U.S. Attorney General Jeff Sessions that he would recuse himself from any investigations into President Donald Trump’s 2016 presidential campaign has raised questions about how often recusals by the Attorney General have happened in the past.”
“While there is no official compilation of recusals, it appears that Attorneys General of the United States have recused themselves at least 15 times since 1989,” according to the Congressional Research Service, which tabulated those 15 instances. See A Brief History of Attorney General Recusal, CRS Legal Sidebar, March 8, 2017.
Other new and updated reports from the Congressional Research Service include the following.
Six Justice Court to Decide Liability of Officials for Post 9/11 Detention, CRS Legal Sidebar, March 7, 2017
What Is the Effect of Enacting a Congressional Review Act Resolution of Disapproval?, CRS Insight, March 3, 2017
WTO Trade Facilitation Agreement, March 3, 2017
Northern Ireland’s Snap Assembly Elections: Outcome and Implications, CRS Insight, March 7, 2017
The Greek Debt Crisis: Continuing Challenges, CRS Insight, March 2, 2017
Marine Corps Amphibious Combat Vehicle (ACV) and Marine Personnel Carrier (MPC): Background and Issues for Congress, updated March 8, 2017
Resolutions of Inquiry in the House, CRS Insight, March 6, 2017
Federal Land Ownership: Overview and Data, updated March 3, 2017
While the U.S. has made significant advancements and remained a global leader in biotechnology over the past decade, the next four years will be critical in determining whether it can sustain that leadership.
As the efficacy of environmental laws has waned, so has their durability. What was once a broadly shared goal – protecting Americans from environmental harm – is now a political football, with rules that whipsaw back and forth depending on who’s in charge.
It takes the average person over 9 hours and costs $160 to file taxes each year. IRS Direct File meant it didn’t have to.
It’s paramount to balance both innovation capabilities and risk as we work towards ensuring that the U.S. bioeconomy is a priority area for both the Nation and for National Security.